ŌURA, creator of its namesake good ring, has confidentially filed paperwork with the US Securities and Trade Fee (SEC) for a proposed preliminary public providing (IPO) of its widespread inventory.
The variety of shares to be supplied and the value vary for the proposed providing haven’t but been decided, the corporate said. In the meantime, the precise timing for the IPO was not specified, with ŌURA stating solely that it’s going to happen after the SEC “completes its assessment course of, topic to market and different circumstances.”
Whereas Oura Ring is assessed as a shopper wellness product for monitoring well being metrics, its software has intersected with the medical gadget trade via varied partnerships, notably within the diabetes area.
Dexcom invested $75m in ŌURA in November 2024, forging a partnership centred on launching integrations to facilitate knowledge circulation between Dexcom’s steady glucose monitoring (CGM) merchandise, together with its glucose biosensors and apps, with ŌURA merchandise. By integrating Dexcom’s CGM knowledge with Oura ring’s wellness metrics similar to sleep, stress, and cardiovascular knowledge, the mixed knowledge is positioned to offer customers insights into facets similar to how poor sleep impacts glucose variability and what meals trigger glucose spikes.
Different corporations which have partnered with ŌURA embody Mira. The femtech firm introduced a collaboration with the firm in February 2026, permitting Oura good ring customers to entry lab-grade hormone testing knowledge.
On 20 Might, ŌURA introduced that it was heading in the right direction to surpass 5 million paid members this quarter, representing a ‘4x’ uptick over the previous two years. The IPO plans observe a $900m Sequence E financing spherical accomplished by the corporate in October 2025. The newest financing put ŌURA at an approximate valuation of $11bn.
On the time of the Sequence E spherical, the corporate revealed that it had achieved greater than $500m in 2024 income, doubling its development from the prior 12 months, and was heading in the right direction to double income once more in 2025, surpassing $1bn in annual gross sales. As of Might 2026, the corporate has not disclosed its 2025 earnings in full.
“Harnessing medtech market alliances, ŌURA units IPO plans in movement” was initially created and printed by Medical System Community, a GlobalData owned model.
The data on this website has been included in good religion for basic informational functions solely. It’s not supposed to quantity to recommendation on which you must rely, and we give no illustration, guarantee or assure, whether or not categorical or implied as to its accuracy or completeness. It’s essential to receive skilled or specialist recommendation earlier than taking, or refraining from, any motion on the premise of the content material on our website.
